Using CAR T Cell Therapy to Treat Solid Tumors

CAR T cells have shown significant success in eradicating hematologic malignancies but face challenges in targeting solid tumors.

• CAR T cells are engineered to recognize and attack specific cancer cells by expressing synthetic receptors.
• While effective against blood cancers, their efficacy in solid tumors remains limited.
• Challenges in the solid tumor microenvironment may hinder the persistence and activity of CAR T cells.
• New strategies are being explored to enhance CAR T cell function in solid tumors.

Simplified